Abstract

Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2020 - Volume 24, Number 5

Page(s): 397-402

Download in electronic PDF format for $75

Abstract

In the formulation of parenteral dosage forms, pH is a critical factor and can be a complicated factor in compounding intravenous admixtures since the additives and the vehicle may have different pH values. This is especially important, as a significant number of parenteral medications require compounding involving dissolution of lyophilized powders; dilution of drug doses for infusion; mixing of dextrose, amino acids, vitamins, and electrolytes for parenteral nutrition; etc. Compounding intravenous admixtures is common practice, but each admixture may present a different set of problems to consider, especially as it relates to pH.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2020 Pg. 397-402	Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 223-229	Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations Author(s): Allen Loyd V Jr
Nov/Dec 2020 Pg. 473-478	Intravenous Admixture Preparation Considerations, Part 7: Stability Issues Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 131-139	Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 44-50	Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 305-309	Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 222-229	Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 478-482	Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 31-38	Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 123-139	Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 215-220	Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 397-409	Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 305-313	Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 311-317	Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 121-126	Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 426-432	Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion Author(s): Desai Narendra R, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A
May/Jun 2022 Pg. 219-228	Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 132-134	Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection Author(s): Zhang Yan-ping, Trissel Lawrence A
Mar/Apr 2002 Pg. 120-122	A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets Author(s): Rice Stephen P
May/Jun 2011 Pg. 259-261	Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations Author(s): Jasti Bhaskara R, Saraf Poonam